Sonnet BioTherapeutics Holdings, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q2 2011 to Q2 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Sonnet BioTherapeutics Holdings, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2011 to Q2 2024.
  • Sonnet BioTherapeutics Holdings, Inc. Entity Common Stock, Shares Outstanding for the quarter ending August 14, 2024 was 5.2M shares, a 86.5% decline year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 5.2M -33.3M -86.5% Aug 14, 2024 10-Q 2024-08-14
Q1 2024 3.11M -24.4M -88.7% May 8, 2024 10-Q 2024-05-14
Q4 2023 3.07M -4.86M -61.3% Dec 11, 2023 10-K 2023-12-14
Q2 2023 38.5M -22.1M -36.4% Aug 7, 2023 10-Q 2023-08-14
Q1 2023 27.5M -33.1M -54.6% May 8, 2023 10-Q 2023-05-10
Q4 2022 7.93M -52.3M -86.8% Dec 14, 2022 10-K 2022-12-15
Q2 2022 60.6M +35.6M +143% Aug 12, 2022 10-Q 2022-08-15
Q1 2022 60.6M +39.4M +186% May 5, 2022 10-Q 2022-05-10
Q4 2021 60.3M +43.1M +251% Dec 10, 2021 10-K 2021-12-17
Q2 2021 25M +11.3M +82.9% Aug 10, 2021 10-Q 2021-08-16
Q1 2021 21.2M +8.79M +70.9% May 10, 2021 10-Q 2021-05-17
Q4 2020 17.2M Dec 8, 2020 10-K 2020-12-17
Q2 2020 13.6M +3.6M +35.9% Aug 12, 2020 10-Q 2020-08-14
Q1 2020 12.4M +8.67M +232% Mar 16, 2020 10-K 2020-03-19
Q3 2019 10.1M +6.36M +171% Nov 7, 2019 10-Q 2019-11-14
Q2 2019 10M +6.34M +171% Aug 6, 2019 10-Q 2019-08-14
Q1 2019 3.73M +510K +15.8% Mar 18, 2019 10-K 2019-04-01
Q3 2018 3.72M +690K +22.8% Nov 9, 2018 10-Q 2018-11-14
Q2 2018 3.71M +1.21M +48.2% Aug 6, 2018 10-Q 2018-08-13
Q1 2018 3.22M -18.8M -85.4% Mar 25, 2018 10-K 2018-03-30
Q3 2017 3.03M -18.9M -86.2% Nov 9, 2017 10-Q 2017-11-13
Q2 2017 2.5M -19.5M -88.6% Aug 10, 2017 10-Q 2017-08-14
Q1 2017 22M +662K +3.1% Mar 23, 2017 10-K 2017-03-31
Q3 2016 22M Nov 8, 2016 10-Q 2016-11-10
Q2 2016 22M +7.72M +54.2% Aug 10, 2016 10-Q 2016-08-11
Q1 2016 21.3M +9.03M +73.4% Mar 25, 2016 10-K 2016-03-31
Q4 2015 21.5M Nov 16, 2015 10-Q 2015-11-16
Q2 2015 14.2M +7.52M +112% Aug 4, 2015 10-Q 2015-08-14
Q1 2015 12.3M +6.02M +95.7% Mar 25, 2015 10-K 2015-04-15
Q3 2014 7.24M +1.93M +36.4% Nov 7, 2014 10-Q 2014-11-14
Q2 2014 6.72M +3.02M +81.5% Aug 5, 2014 10-Q 2014-08-14
Q1 2014 6.29M +2.59M +70% Mar 15, 2014 10-K 2014-03-31
Q3 2013 5.31M Oct 31, 2013 10-Q 2013-11-15
Q2 2013 3.7M +4K +0.11% Aug 5, 2013 10-Q 2013-08-12
Q1 2013 3.7M +1.2M +48% Mar 15, 2013 10-K 2013-04-03
Q4 2012 3.7M Dec 18, 2012 10-Q/A 2012-12-31
Q2 2012 3.7M +1.24M +50.3% Jul 30, 2012 10-Q/A 2013-01-02
Q1 2012 2.5M Apr 30, 2012 10-Q/A 2012-12-28
Q3 2011 2.5M Oct 31, 2011 10-Q 2011-11-14
Q2 2011 2.46M Jul 31, 2011 10-Q 2011-08-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.